Fate Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.

CEO

J. Scott Wolchko

CEOJ. Scott Wolchko

Employees

449

Employees449

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

449

Employees449

FATE Key Statistics

Market cap

1.86B

Market cap1.86B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.01M

Average volume1.01M

High today

$19.40

High today$19.40

Low today

$18.81

Low today$18.81

Open price

$19.01

Open price$19.01

Volume

966.32K

Volume966.32K

52 Week high

$66.56

52 Week high$66.56

52 Week low

$17.10

52 Week low$17.10

Analyst ratings

86%

of 22 ratings

Buy

86.4%

Hold

13.6%

Sell

FATE Earnings

-$0.89

-$0.59

-$0.30

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 27, After Hours

ActualExpected Feb 27, After Hours